- Home
- FTRE vs DXYZ Comparison
FTRE vs DXYZ Comparison
Compare FTRE & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- DXYZ
- Stock Information
- Founded
- FTRE 1996
- DXYZ N/A
- Country
- FTRE United States
- DXYZ
- Employees
- FTRE N/A
- DXYZ N/A
- Industry
- FTRE Medical Specialities
- DXYZ
- Sector
- FTRE Health Care
- DXYZ
- Exchange
- FTRE Nasdaq
- DXYZ Nasdaq
- Market Cap
- FTRE 469.0M
- DXYZ 413.3M
- IPO Year
- FTRE N/A
- DXYZ 2024
- Fundamental
- Price
- FTRE $5.22
- DXYZ $36.38
- Analyst Decision
- FTRE Hold
- DXYZ
- Analyst Count
- FTRE 11
- DXYZ 0
- Target Price
- FTRE $17.10
- DXYZ N/A
- AVG Volume (30 Days)
- FTRE 2.9M
- DXYZ N/A
- Earning Date
- FTRE 08-11-2025
- DXYZ N/A
- Dividend Yield
- FTRE N/A
- DXYZ N/A
- EPS Growth
- FTRE N/A
- DXYZ N/A
- EPS
- FTRE N/A
- DXYZ N/A
- Revenue
- FTRE $2,685,600,000.00
- DXYZ N/A
- Revenue This Year
- FTRE N/A
- DXYZ N/A
- Revenue Next Year
- FTRE $1.36
- DXYZ N/A
- P/E Ratio
- FTRE N/A
- DXYZ N/A
- Revenue Growth
- FTRE N/A
- DXYZ N/A
- 52 Week Low
- FTRE $3.97
- DXYZ N/A
- 52 Week High
- FTRE $28.41
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- FTRE 49.64
- DXYZ N/A
- Support Level
- FTRE $4.81
- DXYZ N/A
- Resistance Level
- FTRE $5.63
- DXYZ N/A
- Average True Range (ATR)
- FTRE 0.35
- DXYZ 0.00
- MACD
- FTRE -0.01
- DXYZ 0.00
- Stochastic Oscillator
- FTRE 30.37
- DXYZ 0.00
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.